Longitudinal study shows increased SUV in myocardial segments post radioablation, suggesting 18FDG-PET/CT as a biomarker for heart health.
In this small hypothesis-generating study, late SUV increases (day 90) were observed in targeted segments, consistent with VT burden reduction. Further longitudinal studies with ¹⁸[F]-FDG-PET/CT after STAR will define how SUV dynamics can be optimally incorporated as a biomarker in practice.
No takes yet. Share an insight, caveat, or question.
Walls et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: